GoHealth, Inc. (NASDAQ: GOCO)

Sector: Financial Services Industry: Insurance Brokers CIK: 0001808220
Market Cap 30.77 Mn
P/B 0.45
P/E -0.15
P/S 0.04
ROIC (Qtr) -40.67
Div Yield % 0.00
Rev 1y % (Qtr) -71.10
Total Debt (Qtr) 616.72 Mn
Debt/Equity (Qtr) 9.05

About

GoHealth, Inc., a prominent player in the healthcare industry, operates under the ticker symbol 'GOCO' and specializes in offering Medicare insurance products and services. Its primary business activities encompass providing Medicare Advantage, Medicare Supplement, and prescription drug plans, along with facilitating a platform for consumers to shop for and enroll in health insurance plans. GoHealth's platform harnesses proprietary technology, machine-learning capabilities, and data science to connect consumers with health insurance plans, enabling...

Read more

Price action

Investment thesis

Bull case

  • Healthy cash reserves of 32.08M provide 6.52x coverage of short-term debt 4.92M, demonstrating strong liquidity position and minimal refinancing risk.
  • Tangible assets of 1.03B provide exceptional 35.30x coverage of deferred revenue 29.20M, showing strong service capability backing.
  • Retained earnings of (647.74M) provide strong 8.61x coverage of other current liabilities (75.22M), indicating earnings quality.
  • Robust tangible asset base of 1.03B provides 9.22x coverage of working capital 111.78M, indicating strong operational backing.
  • R&D investment of 39.34M represents healthy 1.35x of deferred revenue 29.20M, indicating strong future innovation pipeline.

Bear case

  • Investment activities of (10.47M) provide weak support for R&D spending of 39.34M, which is -0.27x, suggesting potentially insufficient investment in innovation relative to other capital deployment.
  • Operating cash flow of (68.27M) provides insufficient coverage of deferred revenue obligations of 29.20M, which is -2.34x, raising concerns about future service delivery capabilities.
  • The company's operating cash flow of (68.27M) shows concerning coverage of stock compensation expenses of 10.91M, with a -6.26 ratio indicating potential earnings quality issues.
  • Free cash flow of (78.73M) provides weak coverage of capital expenditures of 10.47M, with a -7.52 ratio suggesting additional external financing needs for growth initiatives.
  • Operating earnings of (120.97M) show weak coverage of depreciation charges of 110.22M, with a -1.10 ratio indicating high capital intensity and potential reinvestment needs.

Segments Breakdown of Revenue (2024)

Segments Breakdown of Revenue (2024)

Peer comparison

Companies in the Insurance Brokers
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 MMC Marsh & Mclennan Companies, Inc. 92.62 Bn 29.47 4.67 21.43 Bn
2 AON Aon plc 74.51 Bn 27.41 4.38 17.44 Bn
3 AJG Arthur J. Gallagher & Co. 55.76 Bn 51.09 5.25 13.69 Bn
4 BRO Brown & Brown, Inc. 22.82 Bn 108.30 13.93 7.97 Bn
5 WTW Willis Towers Watson Plc 22.12 Bn 46.77 5.80 5.91 Bn
6 ERIE Erie Indemnity Co 13.10 Bn 45.46 4.72 0.00 Bn
7 CRVL Corvel Corp 3.53 Bn 33.49 3.78 0.02 Bn
8 ARX Accelerant Holdings 2.62 Bn 96.44 4.35 0.12 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.57 0.83
EV to Cash from Ops. EV/CFO -8.66 26.54
EV to Debt EV to Debt 0.96 10.83
EV to EBIT EV/EBIT -4.89 15.57
EV to EBITDA EV/EBITDA -3.11 12.32
EV to Free Cash Flow [EV/FCF] EV/FCF -7.51 38.93
EV to Market Cap EV to Market Cap 19.21 -1,866.90
EV to Revenue EV/Rev 0.80 2.59
Price to Book Value [P/B] P/B 0.45 3.17
Price to Earnings [P/E] P/E -0.15 24.79
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 0.83
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 31.35
Dividend per Basic Share Div per Share (Qtr) 0.00 1.08
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 18.16
Interest Coverage Int. cover (Qtr) -1.60 -4.53
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 39.00 423.33
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -9.71 -3.76
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 -1.10
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -379.56 -9.09
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -608.44 -5.72
EBIT Growth (1y) % EBIT 1y % (Qtr) -378.24 8.13
EBT Growth (1y) % EBT 1y % (Qtr) -567.79 -4.46
EPS Growth (1y) % EPS 1y % (Qtr) -351.36 -68.33
FCF Growth (1y) % FCF 1y % (Qtr) -539.03 -67.66
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 4.82 52.95
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.72 0.62
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.16
Cash Ratio Cash Ratio (Qtr) 0.18 0.54
Current Ratio Curr Ratio (Qtr) 1.64 2.11
Debt to Equity Ratio Debt/Equity (Qtr) 9.05 0.93
Interest Cover Ratio Int Coverage (Qtr) -1.60 -4.53
Times Interest Earned Times Interest Earned (Qtr) -1.60 -4.53
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) -1.50 6.16
EBIT Margin % EBIT Margin % (Qtr) -16.38 -108.04
EBT Margin % EBT Margin % (Qtr) -26.60 -14.94
Gross Margin % Gross Margin % (Qtr) 80.50 53.35
Net Profit Margin % Net Margin % (Qtr) -27.00 -17.46